Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Selinexor Combined With Dexamethasone in CAEBV
NCT05347381Phase 3Unknown
- Sponsor
- Beijing Friendship Hospital
- Start
- May 2022
- Primary completion
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of selinexor in chronic active Epstein-Barr virus infection (CAEBV), sponsored by Beijing Friendship Hospital. Status: unknown.
02
Drugs
selinexor
03
Conditions
chronic active Epstein-Barr virus infection (CAEBV)
Beyond the preview
Go deeper on NCT05347381.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05347381.